Superworth

Jazz Pharmaceuticals price to free cash flow JAZZ

Market value divided by free cash flow over the last twelve months, since 2012.

Today, Oct 23, 2026
8.7×
10-year median
9.7×
Against its 10-year history
37th
percentile: 0 is its lowest day, 100 its highest
10-year range
4.0× to 16.3×
Peer median
46.0×

Jazz Pharmaceuticals' price to free cash flow is 8.7× as of Oct 23, 2026.

That is below its ten-year median of 9.7×, close to the middle of its last ten years.

Over that time it ranged from 4.0× in May 2025 to 16.3× in Apr 2017.

The median for 10 large drugmakers of a similar size is 46.0×.

Price to free cash flow over time

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far8.7×7.3×12.5×
20257.8×4.0×8.0×
20246.7×5.9×7.1×
20236.2×5.7×9.3×
20229.3×8.6×14.9×
202110.2×9.7×12.2×
202011.7×7.1×11.7×
20199.8×8.4×10.6×
20189.7×9.3×16.3×
201712.5×12.3×16.3×
201612.6×11.2×19.4×
201517.3×16.6×32.5×
201430.8×24.3×35.3×
201323.7×12.0×25.1×
201216.7×13.7×19.1×

Against its peers

Companies in Drug Manufacturers - General nearest Jazz Pharmaceuticals' size, closest first, today.

CompanyPrice to free cash flow
JAZZJazz Pharmaceuticals8.7×
BMRNBiomarin Pharmaceutical14.7×
CORTCorcept Therapeutics86.8×
PTGXProtagonist Therapeutics68.6×
TGTXTG Therapeutics477×
ALKSAlkermes plc.33.0×
AMRXAmneal Pharmaceuticals50.9×
LGNDLigand Pharmaceuticals46.0×
KNSAKiniksa Pharmaceuticals International32.7×
BIIBBiogen13.7×
INDVIndivior Pharmaceuticalsn/m
Peer median46.0×

What the price to free cash flow tells you

Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.

Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.

More on Jazz Pharmaceuticals

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.